Mokola lyssavirus
Mokola lyssavirus is a virus in the Rhabdoviridae family, specifically within the Lyssavirus genus. It is one of the 16 recognized species of lyssaviruses, which also includes the Rabies virus. Mokola lyssavirus is named after the location in Nigeria where it was first isolated in 1968.
History[edit]
Mokola lyssavirus was first identified in 1968 in the town of Mokola, Nigeria. The virus was isolated from a shrew and a domestic cat, marking the first time a lyssavirus had been found in species other than bats and carnivores. Since its initial discovery, Mokola lyssavirus has been isolated in several other African countries, including Cameroon, Central African Republic, and South Africa.
Transmission and Symptoms[edit]
Mokola lyssavirus is primarily transmitted through the bite of an infected animal. The virus has been found in a variety of mammalian species, including cats, dogs, rodents, and shrews. Once infected, the virus travels to the central nervous system where it causes severe neurological symptoms. These symptoms can include aggression, paralysis, and ultimately death.
Diagnosis and Treatment[edit]
Diagnosis of Mokola lyssavirus is typically made through laboratory testing, which can include polymerase chain reaction (PCR) testing, virus isolation, or serology. There is currently no specific treatment for Mokola lyssavirus. Management of the disease primarily involves supportive care and prevention of secondary infections.
Prevention[edit]
Prevention of Mokola lyssavirus involves avoiding contact with potentially infected animals and vaccination of domestic animals. While there is no specific vaccine for Mokola lyssavirus, the rabies vaccine has been shown to provide some protection.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian